Related Experiment Video
Updated: Jul 4, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Drug-induced diffuse infiltrative pneumopathies]
Raffaele Scala1, Mario Naldi, Cesario Ciccotosto
1UO Pneumologia, UTSIR e Endoscopia Toracica, Ospedale S. Donato, AUSL 8 Arezzo. raffaele_scala@hotmail.com
Abstract:
Drug-induced diffuse infiltrative pneumopathies (DIP) represent an important chapter of respiratory diseases. More than 350 drugs have been described to be potentially pneumo-toxic and the list is constantly increasing. As for other forms of DIP, also for drug-induced lung injury a multidisciplinary approach within pulmonologist, radiologist and pathologist is essential for the better diagnostic accuracy. In this review, clinical-radiological-pathological-therapeutic aspects of the drugs which are more likely to induce DIP in the clinical practice are described.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Atypical Pneumonia
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
